CompletedNot Applicable

In-person vs. Remote Wellness Support

United States56 participantsStarted 2020-11-24

Plain-language summary

The study team will use components of the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) framework to compare Cognitive Adaptation Training (CAT) to Remotely delivered Cognitive Adaptation Training (R-CAT) 1-9 within a managed care organization (MCO), targeting members with serious mental illness (SMI) needing assistance with the regular taking of medication.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Able to give informed consent.
✓. Between the ages of 18 and 65.
✓. Clinical Diagnosis of Major Depressive Disorder, Bipolar disorder, Schizophrenia, or Schizoaffective Disorder
✓. Receiving treatment with oral psychiatric medications.
✓. Have had a hospitalization or emergency department visit in the past year
✓. Have a Medication Possession Ratio (MPR) based upon electronic refill data below 80% at least 1 of the past 4 quarters with at least 1 psychiatric medication
✓. Responsible for taking their own medications
✓. Report on telephone prescreen call with researcher team that they have missed at least 2 doses of medication in the past 3 weeks, that they are willing to take medication and would like remote assistance to take medication more regularly

Exclusion criteria

✕. Substance dependence within the past 2 months
✕. Currently being treated by an ACT team
✕. Documented history of violence or threatening behavior on initial assessment
✕. Receive home visits to assist with medication adherence
✕. Unable to complete baseline assessments

What they're measuring

Acceptance of Intervention-Number of Participants Who Dropped Out of Treatment

Timeframe: Baseline to 6 months

Medication Adherence

Timeframe: Baseline to 6 months

Functional Outcome

Timeframe: Baseline to 6 months note that repeated measures analysis was also used

Trial details

NCT IDNCT04526067

SponsorThe University of Texas Health Science Center at San Antonio

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-11-11

Results submitted2024-04-24

View on ClinicalTrials.gov More Depressive Disorder, Major trials